₹308.30▼ −11.90 · −3.7%from ₹320.20 the session before · 1 Oct 2026 close · NSE end of day
Open
₹319.00
High
₹319.35
Low
₹301.10
Day's range
₹185.7% of the previous close
VWAP
₹306.90close +0.46% from it
Volume, shares
7.1 L1.30× the 20-session average
Turnover, ₹ crore
22
Trades
19,00038 shares per trade
Previous close
₹320.20−11.90 to the close
Price band, next session
₹277.45 – ₹339.1510% either side of the close · dynamic, widened in 5% steps when hit
Day range39% of the way up
₹301.10₹319.35
52-week range66% of the way up
₹124.11 24 Mar₹403.35 1 Sept
−24% from the high · +150% from the low
Futures and options
No derivatives listed on SUVEN
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue ₹4 cr; profit −₹128 cr in the Jun 2026 quarter, consolidated.
Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of SUVEN on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue ₹ cr
Revenue YoY
Profit ₹ cr
Profit YoY
EPS ₹
Market on the day
Jun 2026filed 6 Aug
₹4 cr
—
−₹128 cr
—
-4.84
▼ −2.7%Nifty +0.1% · −2.7 pp
Mar 2026filed 13 May
₹2 cr
—
−₹46 cr
—
-2.02
▼ −1.5%Nifty +1.2% · −2.7 pp
Fundamentals
consolidated · filings to Jun 2026 · close ₹308.30 on 1 Oct
15 times book value, market cap ₹8,700 cr.
Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹8,700 cron 1 Oct · free float ₹3,000 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
15consolidated · balance sheet to Mar 2026
Book value a share
₹20.93consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
₹1a share
Shares outstanding
28 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Healthcare Research, Analytics & Technology · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Research, Analytics & Technology with market cap, price to earnings and price to book
Promoters hold 65.5%, foreign portfolio investors 0.5%, mutual funds 0.0% and banks and financial institutions 2.7%, as filed for the quarter to 8 Jul.
65.5%25.9%
Promoters 65.5%
Foreign portfolio investors 0.5%
Mutual funds 0.0%
Banks and financial institutions 2.7%
Individual investors 25.9%
Others 5.5%
By category, last 3 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of SUVEN by category over the last 3 quarters with the change against the previous quarter
Category
8 Jul
30 Jun
31 Mar
Promoters
65.47▼ −4.61 pp
70.08▼ −0.07 pp
70.15
Foreign portfolio investors
0.48▼ −0.08 pp
0.56▼ −0.35 pp
0.91
Mutual funds
0.010.00 pp
0.01▼ −1.78 pp
1.79
Banks and financial institutions
2.72▼ −0.20 pp
2.92▲ +0.09 pp
2.83
Individual investors
25.87▲ +2.92 pp
22.95▲ +1.93 pp
21.02
Bodies corporate
4.42▲ +2.05 pp
2.37▲ +0.18 pp
2.19
Others
1.03▼ −0.08 pp
1.110.00 pp
1.11
Corporate actions
NSE and BSE records
Nothing upcoming on record; the last was a Annual General Meeting, ex-date 30 Jul 2024.
Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of SUVEN, upcoming first, then the most recent
Ex-date
Action
Amount or ratio
Record date
Source
recent
30 Jul 2024
otherAnnual General Meeting
—
—
NSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
—a share · ex-dates inside the year
Last dividend
—none on record
Price history
264 sessions on record · to 1 Oct · NSE end of day
SUVEN is −17.3% over 20 sessions against Nifty's −6.2%, 24% below its 52-week high, realised volatility 38% annualised.
Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
Window
From ₹
SUVEN %
Nifty 50 %
Difference pp
250 sessionssince 26 Sept
₹209.05
▲ +47%
▼ −9.1%
+57
120 sessionssince 9 Apr
₹177.98
▲ +73%
▼ −5.7%
+79
60 sessionssince 8 Jul
₹317.12
▼ −2.8%
▼ −6.1%
+3.3
20 sessionssince 2 Sept
₹372.84
▼ −17%
▼ −6.2%
−11
5 sessionssince 24 Sept
₹335.04
▼ −8.0%
▼ −2.8%
−5.2
1 sessionsince 30 Sept
₹320.21
▼ −3.7%
▼ −0.88%
−2.8
Averages of the closeclose against each average
5-session average
₹321.98close −4.2% from it
20-session average
₹344.93close −11% from it
50-session average
₹340.86close −9.6% from it
200-session average
₹237.23close +30% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹154.9% of the close
Average day's range, 20
₹134.3% of the close
Volume against 20 sessions
1.30×7.1 L vs 5.6 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
38%≈ ±2.4% a session · moved more than that on 5 of 20
Realised volatility, 60
57%≈ ±3.6% a session · moved more than that on 17 of 60
Realised volatility, 250
57%≈ ±3.6% a session · moved more than that on 55 of 250
Beta to Nifty, 60
1.99moved with Nifty on 38 of 60 sessions
Beta to Nifty, 250
1.29moved with Nifty on 150 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
6 up · 14 downof 20
Last 60 sessions
25 up · 35 downof 60
Last 250 sessions
115 up · 134 downof 249
Best session, 250
▲ +20%18 May
Worst session, 250
▼ −11%5 Jun
0 bulletins on SUVEN
The desk has not written about Suven Life Sciences Limited yet. The tape carries every bulletin as it is published.
About Suven Life Sciences Limited
exchange masters as of 18 Sept 2026 · classification by BSE
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 01:46 am IST
Bulletins
0 · written by the desk · not a recommendation
OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.